{"data":{"matter":{"matter_id":"mat_c430108098e706","slug":"zantac-ndma","name":"Zantac NDMA Cancer Lawsuits","category":"mass_tort","subcategory":"pharma","status":"settled","score":0.62,"score_30d":0.7727,"velocity":-0.285,"headline":"Zantac (ranitidine) NDMA cancer settlements - state court resolutions","summary":"Ranitidine (brand Zantac) was removed from market in 2020 after FDA found it could form the carcinogen NDMA during storage. The federal MDL was largely dismissed in December 2022. State-court cases continued; GSK, Sanofi, Pfizer and Boehringer Ingelheim have reached confidential settlements covering tens of thousands of state cases. Stomach, bladder, esophageal, liver and pancreatic cancer diagnoses with documented Zantac use are the typical eligibility profile.","eligibility_hint":"Took Zantac or generic ranitidine regularly and were diagnosed with stomach, bladder, esophageal, liver, or pancreatic cancer","payout":{"band":"mass_tort","low_cents":1000000,"high_cents":50000000,"low_usd":10000,"high_usd":500000},"keywords":{"products":["zantac","ranitidine","ndma"],"brands":["sanofi","gsk","glaxosmithkline","pfizer","boehringer ingelheim"]},"links":{"primary":"https://www.fda.gov/drugs/drug-safety-and-availability/fda-requests-removal-all-ranitidine-products-zantac-market","self":"https://getclaimscout.com/api/v1/matters/zantac-ndma","html":"https://getclaimscout.com/matters/zantac-ndma","lp":null},"lifecycle":{"first_seen_iso":"2026-05-19T11:12:27Z","last_signal_iso":"2026-10-17T10:41:09Z","mdl_filed_iso":null,"settlement_announced_iso":null,"claims_open_iso":null,"claims_close_iso":null,"narrative_generated_iso":"2026-07-07T10:06:25Z"},"attached_cases_count":0,"embedding_model":null,"embedding_version":1,"schema_version":1},"attached_cases":[],"recent_signals":[{"signal_id":"sig_7b037bd2d0810a","matter_id":"mat_c430108098e706","source":"courtlistener_search","source_id":"cl-search:74975703","kind":"court_filing","title":"CL filing: Deutsche Finance America LLC v. Bayerische Versorgungskammer","summary":"Federal filing in ded, docket 1:26-cv-01337, dated 2026-10-16.","url":"https://www.courtlistener.com/recap/?q=paraquat","score":0.75,"decayed_score":null,"keywords":{"brands":[],"products":[]},"provenance":{"feed":"courtlistener_v4_search","court":"ded","docket_no":"1:26-cv-01337","date_filed":"2026-10-16","source_url":"https://www.courtlistener.com/recap/?q=zantac","retrieved_at":"2026-10-18T10:59:24Z","search_query":"zantac"},"resolved_by":"search_context","resolution_confidence":0.3,"first_seen_iso":"2026-10-17T10:41:09Z","last_seen_iso":"2026-10-18T10:59:24Z","schema_version":1},{"signal_id":"sig_31232ff72514af","matter_id":"mat_c430108098e706","source":"courtlistener_search","source_id":"cl-search:74957230","kind":"court_filing","title":"CL filing: XERIS PHARMACEUTICALS, INC. v. RISING PHARMA HOLDINGS, INC.","summary":"Federal filing in njd, docket 2:26-cv-13358, dated 2026-10-13.","url":"https://www.courtlistener.com/recap/?q=zantac","score":0.75,"decayed_score":null,"keywords":{"brands":[],"products":[]},"provenance":{"feed":"courtlistener_v4_search","court":"njd","docket_no":"2:26-cv-13358","date_filed":"2026-10-13","source_url":"https://www.courtlistener.com/recap/?q=zantac","retrieved_at":"2026-10-18T10:59:24Z","search_query":"zantac"},"resolved_by":"search_context","resolution_confidence":0.3,"first_seen_iso":"2026-10-16T11:20:11Z","last_seen_iso":"2026-10-18T10:59:24Z","schema_version":1},{"signal_id":"sig_02e22ab649a898","matter_id":"mat_c430108098e706","source":"courtlistener_search","source_id":"cl-search:74956760","kind":"court_filing","title":"CL filing: XERIS PHARMACEUTICALS, INC. v. TORRENT PHARMA INC.","summary":"Federal filing in njd, docket 2:26-cv-13355, dated 2026-10-13.","url":"https://www.courtlistener.com/recap/?q=zantac","score":0.75,"decayed_score":null,"keywords":{"brands":[],"products":[]},"provenance":{"feed":"courtlistener_v4_search","court":"njd","docket_no":"2:26-cv-13355","date_filed":"2026-10-13","source_url":"https://www.courtlistener.com/recap/?q=zantac","retrieved_at":"2026-10-18T10:59:25Z","search_query":"zantac"},"resolved_by":"search_context","resolution_confidence":0.3,"first_seen_iso":"2026-10-16T11:20:11Z","last_seen_iso":"2026-10-18T10:59:25Z","schema_version":1},{"signal_id":"sig_0fcea336fe9252","matter_id":"mat_c430108098e706","source":"courtlistener_search","source_id":"cl-search:74860494","kind":"court_filing","title":"CL filing: CUNNINGHAM-BEAMON v. BOEHRINGER INGELHEIM PHARMACEUTICALS, INC.","summary":"Federal filing in paed, docket 2:26-cv-07462, dated 2026-09-28.","url":"https://www.courtlistener.com/recap/?q=zantac","score":0.75,"decayed_score":null,"keywords":{"brands":[],"products":[]},"provenance":{"feed":"courtlistener_v4_search","court":"paed","docket_no":"2:26-cv-07462","date_filed":"2026-09-28","source_url":"https://www.courtlistener.com/recap/?q=zantac","retrieved_at":"2026-10-18T10:59:25Z","search_query":"zantac"},"resolved_by":"search_context","resolution_confidence":0.3,"first_seen_iso":"2026-09-30T12:15:20Z","last_seen_iso":"2026-10-18T10:59:25Z","schema_version":1},{"signal_id":"sig_9001ee87eb9d17","matter_id":"mat_c430108098e706","source":"courtlistener_search","source_id":"cl-search:74860319","kind":"court_filing","title":"CL filing: HOPKINS v. BOEHRINGER INGELHEIM PHARMACEUTICALS, INC.","summary":"Federal filing in paed, docket 2:26-cv-07460, dated 2026-09-28.","url":"https://www.courtlistener.com/recap/?q=zantac","score":0.75,"decayed_score":null,"keywords":{"brands":[],"products":[]},"provenance":{"feed":"courtlistener_v4_search","court":"paed","docket_no":"2:26-cv-07460","date_filed":"2026-09-28","source_url":"https://www.courtlistener.com/recap/?q=zantac","retrieved_at":"2026-10-18T10:59:25Z","search_query":"zantac"},"resolved_by":"search_context","resolution_confidence":0.3,"first_seen_iso":"2026-09-30T12:15:20Z","last_seen_iso":"2026-10-18T10:59:25Z","schema_version":1},{"signal_id":"sig_9da343c39b1d6f","matter_id":"mat_c430108098e706","source":"courtlistener_search","source_id":"cl-search:74860560","kind":"court_filing","title":"CL filing: BROWN v. BOEHRINGER INGELHEIM PHARMACEUTICALS, INC.","summary":"Federal filing in paed, docket 2:26-cv-07463, dated 2026-09-28.","url":"https://www.courtlistener.com/recap/?q=zantac","score":0.75,"decayed_score":null,"keywords":{"brands":[],"products":[]},"provenance":{"feed":"courtlistener_v4_search","court":"paed","docket_no":"2:26-cv-07463","date_filed":"2026-09-28","source_url":"https://www.courtlistener.com/recap/?q=zantac","retrieved_at":"2026-10-18T10:59:25Z","search_query":"zantac"},"resolved_by":"search_context","resolution_confidence":0.3,"first_seen_iso":"2026-09-30T12:15:20Z","last_seen_iso":"2026-10-18T10:59:25Z","schema_version":1},{"signal_id":"sig_5aa04241972769","matter_id":"mat_c430108098e706","source":"courtlistener_search","source_id":"cl-search:74860246","kind":"court_filing","title":"CL filing: SMITH v. BOEHRINGER INGELHEIM PHARMACEUTICALS, INC.","summary":"Federal filing in paed, docket 2:26-cv-07457, dated 2026-09-28.","url":"https://www.courtlistener.com/recap/?q=data breach","score":0.75,"decayed_score":null,"keywords":{"brands":[],"products":[]},"provenance":{"feed":"courtlistener_v4_search","court":"paed","docket_no":"2:26-cv-07457","date_filed":"2026-09-28","source_url":"https://www.courtlistener.com/recap/?q=zantac","retrieved_at":"2026-10-18T10:59:25Z","search_query":"zantac"},"resolved_by":"search_context","resolution_confidence":0.3,"first_seen_iso":"2026-09-29T12:20:16Z","last_seen_iso":"2026-10-18T10:59:25Z","schema_version":1},{"signal_id":"sig_ab346f7732e4bd","matter_id":"mat_c430108098e706","source":"regulations_gov","source_id":"reggov:FDA-2026-P-10693-0066","kind":"regulations_doc","title":"Exhibit 53 - Newman From Powders to Single Crystals","summary":"Background Material","url":"https://www.regulations.gov/document/FDA-2026-P-10693-0066","score":0.5,"decayed_score":null,"keywords":{"brands":["sanofi","gsk","glaxosmithkline","pfizer","boehringer ingelheim"],"products":["zantac","ranitidine","ndma"]},"provenance":{"feed":"regulations_gov_v4","doc_type":"Supporting & Related Material","file_url":null,"agency_id":"FDA","source_url":"https://www.regulations.gov/document/FDA-2026-P-10693-0066","posted_date":"2026-09-15T04:00:00Z","retrieved_at":"2026-10-18T10:50:58Z"},"resolved_by":"search_context","resolution_confidence":0.3,"first_seen_iso":"2026-09-16T10:55:39Z","last_seen_iso":"2026-10-18T10:50:58Z","schema_version":1},{"signal_id":"sig_4f913fe3f742e8","matter_id":"mat_c430108098e706","source":"regulations_gov","source_id":"reggov:FDA-2026-P-10693-0051","kind":"regulations_doc","title":"Exhibit 38 - Draft Guidance - Sameness Evaluation in ANDA","summary":"Background Material","url":"https://www.regulations.gov/document/FDA-2026-P-10693-0051","score":0.5,"decayed_score":null,"keywords":{"brands":["sanofi","gsk","glaxosmithkline","pfizer","boehringer ingelheim"],"products":["zantac","ranitidine","ndma"]},"provenance":{"feed":"regulations_gov_v4","doc_type":"Supporting & Related Material","file_url":null,"agency_id":"FDA","source_url":"https://www.regulations.gov/document/FDA-2026-P-10693-0051","posted_date":"2026-09-15T04:00:00Z","retrieved_at":"2026-10-18T10:50:58Z"},"resolved_by":"search_context","resolution_confidence":0.3,"first_seen_iso":"2026-09-16T10:55:39Z","last_seen_iso":"2026-10-18T10:50:58Z","schema_version":1},{"signal_id":"sig_a8a6222f05f3da","matter_id":"mat_c430108098e706","source":"regulations_gov","source_id":"reggov:FDA-2026-P-10693-0070","kind":"regulations_doc","title":"Exhibit 57 - Guidance - ANDAs Pharmaceutical Solid Polymorphism","summary":"Background Material","url":"https://www.regulations.gov/document/FDA-2026-P-10693-0070","score":0.5,"decayed_score":null,"keywords":{"brands":["sanofi","gsk","glaxosmithkline","pfizer","boehringer ingelheim"],"products":["zantac","ranitidine","ndma"]},"provenance":{"feed":"regulations_gov_v4","doc_type":"Supporting & Related Material","file_url":null,"agency_id":"FDA","source_url":"https://www.regulations.gov/document/FDA-2026-P-10693-0070","posted_date":"2026-09-15T04:00:00Z","retrieved_at":"2026-10-18T10:50:58Z"},"resolved_by":"search_context","resolution_confidence":0.3,"first_seen_iso":"2026-09-16T10:55:38Z","last_seen_iso":"2026-10-18T10:50:58Z","schema_version":1},{"signal_id":"sig_16d408fb56509e","matter_id":"mat_c430108098e706","source":"regulations_gov","source_id":"reggov:FDA-2026-P-10785-0004","kind":"regulations_doc","title":"Attachment 2","summary":"Background Material","url":"https://www.regulations.gov/document/FDA-2026-P-10785-0004","score":0.5,"decayed_score":null,"keywords":{"brands":["sanofi","gsk","glaxosmithkline","pfizer","boehringer ingelheim"],"products":["zantac","ranitidine","ndma"]},"provenance":{"feed":"regulations_gov_v4","doc_type":"Supporting & Related Material","file_url":null,"agency_id":"FDA","source_url":"https://www.regulations.gov/document/FDA-2026-P-10785-0004","posted_date":"2026-09-15T04:00:00Z","retrieved_at":"2026-10-18T10:50:58Z"},"resolved_by":"search_context","resolution_confidence":0.3,"first_seen_iso":"2026-09-16T10:55:38Z","last_seen_iso":"2026-10-18T10:50:58Z","schema_version":1},{"signal_id":"sig_5ea110a1a12d3d","matter_id":"mat_c430108098e706","source":"regulations_gov","source_id":"reggov:FDA-2026-P-10785-0006","kind":"regulations_doc","title":"Attachment 4","summary":"Background Material","url":"https://www.regulations.gov/document/FDA-2026-P-10785-0006","score":0.5,"decayed_score":null,"keywords":{"brands":["sanofi","gsk","glaxosmithkline","pfizer","boehringer ingelheim"],"products":["zantac","ranitidine","ndma"]},"provenance":{"feed":"regulations_gov_v4","doc_type":"Supporting & Related Material","file_url":null,"agency_id":"FDA","source_url":"https://www.regulations.gov/document/FDA-2026-P-10785-0006","posted_date":"2026-09-15T04:00:00Z","retrieved_at":"2026-10-18T10:50:58Z"},"resolved_by":"search_context","resolution_confidence":0.3,"first_seen_iso":"2026-09-16T10:55:38Z","last_seen_iso":"2026-10-18T10:50:58Z","schema_version":1},{"signal_id":"sig_571c8879a92aa4","matter_id":"mat_c430108098e706","source":"regulations_gov","source_id":"reggov:FDA-2026-P-10693-0080","kind":"regulations_doc","title":"Exhibit 67 - FDA - Paragraph IV Patent Certifications","summary":"Background Material","url":"https://www.regulations.gov/document/FDA-2026-P-10693-0080","score":0.5,"decayed_score":null,"keywords":{"brands":["sanofi","gsk","glaxosmithkline","pfizer","boehringer ingelheim"],"products":["zantac","ranitidine","ndma"]},"provenance":{"feed":"regulations_gov_v4","doc_type":"Supporting & Related Material","file_url":null,"agency_id":"FDA","source_url":"https://www.regulations.gov/document/FDA-2026-P-10693-0080","posted_date":"2026-09-15T04:00:00Z","retrieved_at":"2026-10-18T10:50:58Z"},"resolved_by":"search_context","resolution_confidence":0.3,"first_seen_iso":"2026-09-16T10:55:09Z","last_seen_iso":"2026-10-18T10:50:58Z","schema_version":1},{"signal_id":"sig_38e0beeae0a262","matter_id":"mat_c430108098e706","source":"courtlistener_search","source_id":"cl-search:74774890","kind":"court_filing","title":"CL filing: CRITES v. BOEHRINGER INGELHEIM PHARMACEUTICALS, INC.","summary":"Federal filing in paed, docket 2:26-cv-06898, dated 2026-09-10.","url":"https://www.courtlistener.com/recap/?q=zantac","score":0.75,"decayed_score":null,"keywords":{"brands":[],"products":[]},"provenance":{"feed":"courtlistener_v4_search","court":"paed","docket_no":"2:26-cv-06898","date_filed":"2026-09-10","source_url":"https://www.courtlistener.com/recap/?q=zantac","retrieved_at":"2026-10-18T10:59:25Z","search_query":"zantac"},"resolved_by":"search_context","resolution_confidence":0.3,"first_seen_iso":"2026-09-12T10:19:34Z","last_seen_iso":"2026-10-18T10:59:25Z","schema_version":1},{"signal_id":"sig_ba439001c2d393","matter_id":"mat_c430108098e706","source":"courtlistener_search","source_id":"cl-search:74759397","kind":"court_filing","title":"CL filing: WILGUESS v. BOEHRINGER INGELHEIM PHARMACEUTICALS, INC.","summary":"Federal filing in paed, docket 2:26-cv-06735, dated 2026-09-08.","url":"https://www.courtlistener.com/recap/?q=data breach","score":0.75,"decayed_score":null,"keywords":{"brands":[],"products":[]},"provenance":{"feed":"courtlistener_v4_search","court":"paed","docket_no":"2:26-cv-06735","date_filed":"2026-09-08","source_url":"https://www.courtlistener.com/recap/?q=zantac","retrieved_at":"2026-10-18T10:59:25Z","search_query":"zantac"},"resolved_by":"search_context","resolution_confidence":0.3,"first_seen_iso":"2026-09-09T10:56:34Z","last_seen_iso":"2026-10-18T10:59:25Z","schema_version":1},{"signal_id":"sig_4a30fb9521bd59","matter_id":"mat_c430108098e706","source":"courtlistener_search","source_id":"cl-search:74747310","kind":"court_filing","title":"CL filing: WILLIAMSON v. FERRARI","summary":"Federal filing in paed, docket 2:26-cv-06650, dated 2026-09-02.","url":"https://www.courtlistener.com/recap/?q=data breach","score":0.75,"decayed_score":null,"keywords":{"brands":[],"products":[]},"provenance":{"feed":"courtlistener_v4_search","court":"paed","docket_no":"2:26-cv-06650","date_filed":"2026-09-02","source_url":"https://www.courtlistener.com/recap/?q=zantac","retrieved_at":"2026-10-18T10:59:25Z","search_query":"zantac"},"resolved_by":"search_context","resolution_confidence":0.3,"first_seen_iso":"2026-09-04T10:47:45Z","last_seen_iso":"2026-10-18T10:59:25Z","schema_version":1},{"signal_id":"sig_7c8b7ba53e469c","matter_id":"mat_c430108098e706","source":"courtlistener_search","source_id":"cl-search:74736391","kind":"court_filing","title":"CL filing: LOVELESS v. BOEHRINGER INGELHEIM PHARMACEUTICALS, INC.","summary":"Federal filing in paed, docket 2:26-cv-06597, dated 2026-09-01.","url":"https://www.courtlistener.com/recap/?q=zantac","score":0.75,"decayed_score":null,"keywords":{"brands":[],"products":[]},"provenance":{"feed":"courtlistener_v4_search","court":"paed","docket_no":"2:26-cv-06597","date_filed":"2026-09-01","source_url":"https://www.courtlistener.com/recap/?q=zantac","retrieved_at":"2026-09-29T12:22:51Z","search_query":"zantac"},"resolved_by":"search_context","resolution_confidence":0.3,"first_seen_iso":"2026-09-03T10:54:48Z","last_seen_iso":"2026-09-29T12:22:51Z","schema_version":1},{"signal_id":"sig_edc83d3956cde7","matter_id":"mat_c430108098e706","source":"courtlistener_search","source_id":"cl-search:74736358","kind":"court_filing","title":"CL filing: DAVIDSON v. BOEHRINGER INGELHEIM PHARMACEUTICALS, INC.","summary":"Federal filing in paed, docket 2:26-cv-06596, dated 2026-09-01.","url":"https://www.courtlistener.com/recap/?q=zantac","score":0.75,"decayed_score":null,"keywords":{"brands":[],"products":[]},"provenance":{"feed":"courtlistener_v4_search","court":"paed","docket_no":"2:26-cv-06596","date_filed":"2026-09-01","source_url":"https://www.courtlistener.com/recap/?q=zantac","retrieved_at":"2026-09-29T12:22:51Z","search_query":"zantac"},"resolved_by":"search_context","resolution_confidence":0.3,"first_seen_iso":"2026-09-03T10:54:48Z","last_seen_iso":"2026-09-29T12:22:51Z","schema_version":1},{"signal_id":"sig_c894153b98c9ff","matter_id":"mat_c430108098e706","source":"courtlistener_search","source_id":"cl-search:74736316","kind":"court_filing","title":"CL filing: ALSTON v. BOEHRINGER INGELHEIM PHARMACEUTICALS, INC.","summary":"Federal filing in paed, docket 2:26-cv-06594, dated 2026-09-01.","url":"https://www.courtlistener.com/recap/?q=zantac","score":0.75,"decayed_score":null,"keywords":{"brands":[],"products":[]},"provenance":{"feed":"courtlistener_v4_search","court":"paed","docket_no":"2:26-cv-06594","date_filed":"2026-09-01","source_url":"https://www.courtlistener.com/recap/?q=zantac","retrieved_at":"2026-09-29T12:22:51Z","search_query":"zantac"},"resolved_by":"search_context","resolution_confidence":0.3,"first_seen_iso":"2026-09-03T10:54:48Z","last_seen_iso":"2026-09-29T12:22:51Z","schema_version":1},{"signal_id":"sig_97e55f13b3e724","matter_id":"mat_c430108098e706","source":"courtlistener_search","source_id":"cl-search:74736242","kind":"court_filing","title":"CL filing: GONZALEZ v. BOEHRINGER INGELHEIM PHARMACEUTICALS, INC.","summary":"Federal filing in paed, docket 2:26-cv-06589, dated 2026-09-01.","url":"https://www.courtlistener.com/recap/?q=zantac","score":0.75,"decayed_score":null,"keywords":{"brands":[],"products":[]},"provenance":{"feed":"courtlistener_v4_search","court":"paed","docket_no":"2:26-cv-06589","date_filed":"2026-09-01","source_url":"https://www.courtlistener.com/recap/?q=zantac","retrieved_at":"2026-09-03T10:54:48Z","search_query":"zantac"},"resolved_by":"search_context","resolution_confidence":0.3,"first_seen_iso":"2026-09-03T10:54:48Z","last_seen_iso":"2026-09-03T10:54:48Z","schema_version":1},{"signal_id":"sig_660b3de1526246","matter_id":"mat_c430108098e706","source":"courtlistener_search","source_id":"cl-search:74736441","kind":"court_filing","title":"CL filing: GIBSON v. BOEHRINGER INGELHEIM PHARMACEUTICALS, INC.","summary":"Federal filing in paed, docket 2:26-cv-06599, dated 2026-09-01.","url":"https://www.courtlistener.com/recap/?q=zantac","score":0.75,"decayed_score":null,"keywords":{"brands":[],"products":[]},"provenance":{"feed":"courtlistener_v4_search","court":"paed","docket_no":"2:26-cv-06599","date_filed":"2026-09-01","source_url":"https://www.courtlistener.com/recap/?q=zantac","retrieved_at":"2026-10-16T11:20:12Z","search_query":"zantac"},"resolved_by":"search_context","resolution_confidence":0.3,"first_seen_iso":"2026-09-03T10:54:48Z","last_seen_iso":"2026-10-16T11:20:12Z","schema_version":1},{"signal_id":"sig_2986192accfed1","matter_id":"mat_c430108098e706","source":"courtlistener_search","source_id":"cl-search:74736315","kind":"court_filing","title":"CL filing: STEWART v. BOEHRINGER INGELHEIM PHARMACEUTICALS, INC.","summary":"Federal filing in paed, docket 2:26-cv-06595, dated 2026-09-01.","url":"https://www.courtlistener.com/recap/?q=zantac","score":0.75,"decayed_score":null,"keywords":{"brands":[],"products":[]},"provenance":{"feed":"courtlistener_v4_search","court":"paed","docket_no":"2:26-cv-06595","date_filed":"2026-09-01","source_url":"https://www.courtlistener.com/recap/?q=zantac","retrieved_at":"2026-09-28T13:11:39Z","search_query":"zantac"},"resolved_by":"search_context","resolution_confidence":0.3,"first_seen_iso":"2026-09-03T10:54:48Z","last_seen_iso":"2026-09-28T13:11:39Z","schema_version":1},{"signal_id":"sig_b731e11572a769","matter_id":"mat_c430108098e706","source":"courtlistener_search","source_id":"cl-search:74736314","kind":"court_filing","title":"CL filing: WISEMAN v. BOEHRINGER INGELHEIM PHARMACEUTICALS, INC.","summary":"Federal filing in paed, docket 2:26-cv-06593, dated 2026-09-01.","url":"https://www.courtlistener.com/recap/?q=zantac","score":0.75,"decayed_score":null,"keywords":{"brands":[],"products":[]},"provenance":{"feed":"courtlistener_v4_search","court":"paed","docket_no":"2:26-cv-06593","date_filed":"2026-09-01","source_url":"https://www.courtlistener.com/recap/?q=zantac","retrieved_at":"2026-09-11T10:50:33Z","search_query":"zantac"},"resolved_by":"search_context","resolution_confidence":0.3,"first_seen_iso":"2026-09-03T10:54:48Z","last_seen_iso":"2026-09-11T10:50:33Z","schema_version":1},{"signal_id":"sig_6a38ebe1a236f8","matter_id":"mat_c430108098e706","source":"courtlistener_search","source_id":"cl-search:74736243","kind":"court_filing","title":"CL filing: HATTON v. BOEHRINGER INGELHEIM PHARMACEUTICALS, INC.","summary":"Federal filing in paed, docket 2:26-cv-06588, dated 2026-09-01.","url":"https://www.courtlistener.com/recap/?q=zantac","score":0.75,"decayed_score":null,"keywords":{"brands":[],"products":[]},"provenance":{"feed":"courtlistener_v4_search","court":"paed","docket_no":"2:26-cv-06588","date_filed":"2026-09-01","source_url":"https://www.courtlistener.com/recap/?q=zantac","retrieved_at":"2026-09-08T10:49:06Z","search_query":"zantac"},"resolved_by":"search_context","resolution_confidence":0.3,"first_seen_iso":"2026-09-03T10:54:48Z","last_seen_iso":"2026-09-08T10:49:06Z","schema_version":1},{"signal_id":"sig_bcf694c109f192","matter_id":"mat_c430108098e706","source":"courtlistener_search","source_id":"cl-search:74736439","kind":"court_filing","title":"CL filing: MERMER v. BOEHRINGER INGELHEIM PHARMACEUTICALS, INC.","summary":"Federal filing in paed, docket 2:26-cv-06598, dated 2026-09-01.","url":"https://www.courtlistener.com/recap/?q=zantac","score":0.75,"decayed_score":null,"keywords":{"brands":[],"products":[]},"provenance":{"feed":"courtlistener_v4_search","court":"paed","docket_no":"2:26-cv-06598","date_filed":"2026-09-01","source_url":"https://www.courtlistener.com/recap/?q=zantac","retrieved_at":"2026-10-15T11:26:09Z","search_query":"zantac"},"resolved_by":"search_context","resolution_confidence":0.3,"first_seen_iso":"2026-09-03T10:54:48Z","last_seen_iso":"2026-10-15T11:26:09Z","schema_version":1}]},"meta":{"api_version":"v1","schema_version":1,"self":"https://getclaimscout.com/api/v1/matters/zantac-ndma","docs":"https://getclaimscout.com/openapi.json","llms_txt":"https://getclaimscout.com/llms.txt"}}